Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Netflix
NFLX
|
+$385M |
| 2 |
Microsoft
MSFT
|
+$368M |
| 3 |
Berkshire Hathaway Class A
BRK.A
|
+$298M |
| 4 |
Delta Air Lines
DAL
|
+$208M |
| 5 |
Carnival Corporation Ltd
CCL
|
+$203M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$1.34B |
| 2 |
Tesla
TSLA
|
+$353M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$303M |
| 4 |
NVIDIA
NVDA
|
+$290M |
| 5 |
Boeing
BA
|
+$286M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.27% |
| 2 | Healthcare | 18.47% |
| 3 | Consumer Discretionary | 12.34% |
| 4 | Consumer Staples | 10.13% |
| 5 | Industrials | 9.92% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
QXO
3251
QXO Inc
QXO
$14.6B
| $99K | ﹤0.01% |
3,783
+395
| +12% | +$11.1K |
|
|
BVC
3252
BitVentures Limited Ordinary Shares
BVC
$1.76B
| $99K | ﹤0.01% |
13,800
+200
| +1% | +$1.44K |
|
|
CLVR
3253
DELISTED
Clever Leaves Holdings Inc. Common Shares
CLVR
| $98K | ﹤0.01% |
28,489
+4,901
| +21% | +$26.5K |
|
3254
Werewolf Therapeutics
HOWL
$17.9M
| $97K | ﹤0.01% |
45,200
+2,300
| +5% | +$6.34K |
|
3255
Allogene Therapeutics
ALLO
$635M
| $96K | ﹤0.01% |
30,282
-221,618
| -88% | -$971K |
|
3256
ASP Isotopes
ASPI
$521M
| $96K | ﹤0.01% |
100,879
-378,121
| -79% | -$390K |
|
3257
8x8 Inc
EGHT
$292M
| $96K | ﹤0.01% |
38,030
-285,758
| -88% | -$1.02M |
|
3258
Achieve Life Sciences
ACHV
$649M
| $95K | ﹤0.01% |
22,100
-17,500
| -44% | -$88.2K |
|
3259
Laird Superfood
LSF
$43.7M
| $95K | ﹤0.01% |
92,200
+2,100
| +2% | +$2.26K |
|
3260
Pluri
PLUR
$17M
| $95K | ﹤0.01% |
19,738
+6,588
| +50% | +$36.6K |
|
|
ZENV
3261
DELISTED
Zenvia
ZENV
| $95K | ﹤0.01% |
90,200
+41,000
| +83% | +$36.9K |
|
3262
Fortress Biotech
FBIO
$91.7M
| $94K | ﹤0.01% |
21,575
+6,347
| +42% | +$43.5K |
|
|
ONCT
3263
DELISTED
Oncternal Therapeutics, Inc. Common Stock
ONCT
| $94K | ﹤0.01% |
15,665
+1,315
| +9% | +$9.26K |
|
3264
a.k.a. Brands
AKA
$124M
| $93K | ﹤0.01% |
17,875
-19,125
| -52% | -$108K |
|
3265
Enlivex Ltd
ENLV
$36.5M
| $93K | ﹤0.01% |
3,926
+147
| +4% | +$5.09K |
|
|
VBNK
3266
VersaBank
VBNK
$631M
| $93K | ﹤0.01% |
+11,900
| New | +$96.4K |
|
|
RVLP
3267
DELISTED
RVL Pharmaceuticals plc Ordinary Shares
RVLP
| $93K | ﹤0.01% |
1,079,515
+384,600
| +55% | +$111K |
|
|
UBX
3268
DELISTED
Unity Biotechnology
UBX
| $92K | ﹤0.01% |
38,371
-4,100
| -10% | -$10.9K |
|
|
CBD
3269
DELISTED
Companhia Brasileira de Distribuicao
CBD
| $92K | ﹤0.01% |
137,900
-15,200
| -10% | -$45.4K |
|
3270
Dominari Holdings
DOMH
$58.3M
| $91K | ﹤0.01% |
39,326
+2,000
| +5% | +$5.66K |
|
3271
Mustang Bio
MBIO
$4.37M
| $91K | ﹤0.01% |
884
-4
| -0.5% | -$776 |
|
|
ZFOX
3272
DELISTED
ZeroFox Holdings, Inc. Common Stock
ZFOX
| $90K | ﹤0.01% |
101,970
-24,430
| -19% | -$26.1K |
|
|
PHX
3273
DELISTED
PHX Minerals
PHX
| $89K | ﹤0.01% |
24,392
-85,640
| -78% | -$287K |
|
|
VSTA
3274
DELISTED
Vasta Platform
VSTA
| $89K | ﹤0.01% |
21,500
+1,200
| +6% | +$4.39K |
|
|
BCEL
3275
DELISTED
Atreca, Inc. Class A Common Stock
BCEL
| $89K | ﹤0.01% |
341,924
+26,300
| +8% | +$16.6K |
|
Similar funds
Renaissance Technologies's Q3 2023 Portfolio in Review
As of Q3 2023, Renaissance Technologies held 4,329 positions worth $58.7B, down 15% from $69.4B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Renaissance Technologies withdrew a net $8.34B in Q3 2023, closing 714 positions and reducing 1,794 holdings. Its most notable exit was Chevron, an estimated $185M position sold in full.
By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 20% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Renaissance Technologies opened a new position in D.R. Horton worth $125M.
- Renaissance Technologies's largest Q3 2023 buy was D.R. Horton: 1,159,438 shares worth $125M.
- Renaissance Technologies added most to Netflix in Q3 2023, an estimated $385M increase.
- Renaissance Technologies's biggest Q3 2023 reduction was Meta Platforms (Facebook), cutting an estimated $1.34B.
- Renaissance Technologies fully exited Chevron in Q3 2023, selling an estimated $185M.
- Renaissance Technologies's ten largest holdings make up 12% of its $58.7B portfolio in Q3 2023.
- Renaissance Technologies opened 464 new positions and closed 714 in Q3 2023.
- Renaissance Technologies's portfolio value fell 15% quarter-over-quarter to $58.7B.
Based on Renaissance Technologies's 13F filing for Q3 2023, filed 14 Nov 2023.